Analysts Set Ryan Specialty Holdings, Inc. (NYSE:RYAN) Price Target at $54.25

Shares of Ryan Specialty Holdings, Inc. (NYSE:RYANGet Free Report) have been given an average rating of “Hold” by the nine brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $54.25.

Several research firms recently weighed in on RYAN. Keefe, Bruyette & Woods boosted their target price on Ryan Specialty from $56.00 to $62.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 10th. Wells Fargo & Company upped their target price on Ryan Specialty from $57.00 to $58.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. JPMorgan Chase & Co. lifted their price target on Ryan Specialty from $47.00 to $49.00 and gave the stock an “underweight” rating in a research report on Monday, April 8th. Citigroup increased their price objective on Ryan Specialty from $49.00 to $52.00 and gave the company a “neutral” rating in a report on Wednesday, February 28th. Finally, JMP Securities reiterated a “market perform” rating on shares of Ryan Specialty in a research note on Monday, April 15th.

View Our Latest Analysis on Ryan Specialty

Ryan Specialty Stock Up 0.6 %

Shares of Ryan Specialty stock opened at $51.52 on Thursday. Ryan Specialty has a 52-week low of $39.44 and a 52-week high of $56.51. The company has a 50 day moving average of $51.68 and a 200 day moving average of $46.90. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 1.98. The company has a market capitalization of $13.41 billion, a P/E ratio of 101.02 and a beta of 0.52.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.35 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.35. The company had revenue of $532.90 million for the quarter, compared to analysts’ expectations of $524.08 million. Ryan Specialty had a return on equity of 44.84% and a net margin of 9.36%. Ryan Specialty’s quarterly revenue was up 22.5% on a year-over-year basis. During the same period last year, the firm earned $0.27 earnings per share. As a group, research analysts forecast that Ryan Specialty will post 1.77 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently announced a None dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 13th were given a dividend of $0.34 per share. The ex-dividend date was Tuesday, March 12th. Ryan Specialty’s payout ratio is currently 86.27%.

Institutional Investors Weigh In On Ryan Specialty

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. California Public Employees Retirement System purchased a new position in Ryan Specialty during the third quarter worth $5,041,000. American Century Companies Inc. lifted its position in shares of Ryan Specialty by 17.7% in the third quarter. American Century Companies Inc. now owns 1,624,944 shares of the company’s stock valued at $78,647,000 after acquiring an additional 244,490 shares in the last quarter. Boston Partners acquired a new stake in shares of Ryan Specialty during the third quarter valued at $50,090,000. Algert Global LLC purchased a new stake in Ryan Specialty during the 3rd quarter worth about $1,706,000. Finally, UBS Group AG raised its stake in Ryan Specialty by 134.9% in the 3rd quarter. UBS Group AG now owns 138,413 shares of the company’s stock valued at $6,699,000 after purchasing an additional 79,478 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

(Get Free Report

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.